I’m interested in the provisionality of what is and the fragility of making sense of the world.

Nicolas Delaleu

Statement

Nicolas Delaleu thinks of Art and Science as two closely related aspects of human curiosity. Organized within separate, evolving and often competing systems of abstraction, he regrets the lack of modes of expression connecting the two.
With a conviction that the latter may serve as a bridge to a reality that keeps intact a genuine affection for life itself, he treats creation initially as research projects.
Subsequently, findings materialize as objects and spaces where visitors are invited to contemplate and eventually reconcile aspects of rational, empirical, conceptual and esthetic truths.

Portrait of Nicolas Delaleu: Artist and scientist exploring the co-evolution of life and the idea of humankind in light of technological revolutions and our ambiguous perception of reality.

About

Nicolas Delaleu holds a vocational diploma in bioengineering, certifications in science communication and animal sciences, as well as a PhD in experimental immunology earned in Switzerland and Norway.

Involved with the genomics revolution from its infancy, he subsequently acquired credentials in network biology, bioinformatics and data science including developing novel visualization methodologies. In his work as a Research Group Leader, as the Founder of 2cSysBioMed and Director and Head of Computational Biology and AI, he pioneers molecular data-driven decision-making to make personalized precision medicine a reality.

Realizing that advancing into a future that refers to more than later in time, equally depends on modeling abstract ideas into novel interpretational structures and tangible expressions thereof, led him to engage in a professional creative practice.

He thereby investigates the co-evolution of life and the idea of humankind in light of technological revolutions and our ambiguous perception of reality.

A person does what he does because he sees the world as he sees it. – Alfred Korzybski

During his 6-year participation in Klavdij Sluban’s LeMasterklass, he has expanded his practice from contemporary photography to also conceive relational installations.

Using generative, statistical and 3D-modeling, machine learning, video, and musical composition, he thus investigates the redrawing of the object-subject divide ensuing the genomics and data science revolution in an immersive fashion.

Biographical sketch

Work experience

2024 –            Director, Head of Computational Biology & AI (data-driven decision-making at the intersection of science, medical affairs and business strategy)

  • Galderma SA, Lausanne, Switzerland

2017 –             Founder, Chief Data Scientist & Immunologist (big data-driven decision-making)

2023 – 2024    Senior Computational Biologist (big data-driven drug development for phase 3)

  • Galderma SA, Lausanne, Switzerland

2017 – 2020    Translational Medicine Expert and Bioinformatician (prostate cancer)

  • Institute of Oncology Research, Bellinzona, Switzerland

2013 – 2017    Leader – Omics Data Analysis and Visualization Group

  • Department of Clinical Science, University of Bergen (UiB), Norway

2009 – 2013    Postdoc & Project Manager (drug development & systems biology)

  • Department of Clinical Science, UiB, Norway

2008                Research Scientist (bioinformatics & data visualization)

  • Innovest, Bergen, Norway

2002 – 2004    Scientific Assistant (autoimmunity & Sjögren’s syndrome)

  • Geriatric and Special Care Dentistry, University of Zürich, Switzerland

1999 – 2002    Bioengineer & Scientific Assistant (inflammation & biocompatibility)

  • Oral Cell Biology, University of Bern, Switzerland

1997 – 1999    Bioengineer (vaccinology)

  • Crucell, Bern, Switzerland

Education (selection)

2020 – 2026    Art school LeMasterklass with Klavdij Sluban

  • Tailor-made mentorship involving photography, video, installations, 3D-modeling and musical composition, Paris, France

2014                Workshop with Michael Ackerman

  • Contemporary photography, Lugano, Switzerland

2005 – 2008    PhD fellow (experimental immunotherapy and biomarker research)

  • Broegelmann Research Laboratory, UiB, Norway

1994 – 1997    Bioengineer Federal VET (molecular biology and virology)

  • Crucell, Bern, Switzerland

Grants

2000 –             Travel grants and project support ≈ $ 120’000.-

2013                Bergen Medical Research Foundation ≈ $ 750’000.-

  • Formation of the Omics Data Analysis and Visualization Group

2009                The Research Council of Norway ≈ $ 1’300’000.-

  • Mucosal vaccination against autoimmune disease

Publication metrics

38 peer-reviewed articles (15 as first or co-first, 8 as corresponding or last author) and 2 book chapters (1 as first author) and 1 PhD thesis (ISBN 978-82-308-0597-8).

  • Top Journals: Nature Genetics, Nature Cancer, Nature Immunology, Kidney International, Annals of Rheumatic Diseases, Nature Communications, Cell Reports, Arthritis & Rheumatology and Drug Discovery Today.

Google Scholar as per 03.01.2026: Citations = 3052, h-index = 28, i10-index = 33

Language ability

Fluent: English & German / Advanced: French & Norwegian / Basic: Italian

© 2026 I Nicolas Delaleu